⌘K

Login Start Free

Home/Filings/4/0001437749-25-006736

4//SEC Filing

Robinson Chandler 4

Accession 0001437749-25-006736

CIK 0001645469other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 9:24 PM ET

Size

18.1 KB

Accession

0001437749-25-006736

Insider Transaction Report

Form 4

Period: 2025-03-04

Monopar TherapeuticsMNPR

Robinson Chandler

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2025-03-04+6,002→ 64,850 total
Award
Restricted Stock Units
2025-03-04+79,899→ 104,777 total
Exercise: $0.00→ Common Stock (79,899 underlying)
Tax Payment
Common Stock
2025-03-04$31.70/sh−1,759$55,760→ 63,091 total
Award
Stock Options
2025-03-04+85,759→ 85,759 total
Exercise: $31.70Exp: 2035-03-04→ Common Stock (85,759 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-04−6,002→ 98,775 total
→ Common Stock (6,002 underlying)

Holdings

Common Stock
(indirect: See Footnote)
855,589

Footnotes (6)

[F1]Represents shares acquired on vesting and settlement of restricted stock units.
[F2]Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
[F3]6,647 options vested on the grant date. Remainder of options vest 6/48ths on June 30, 2025, and 1/48th per month thereafter.
[F4]6,002 restricted stock units vested on the grant date. Remainder of restricted stock units vest 6/48ths on June 30, 2025, and 3/48ths per quarter thereafter.
[F5]As a manager of Tactic Pharma LLC, Dr. Robinson may be deemed to share voting and dispositive power over these 855,589 shares. Dr. Robinson disclaims beneficial ownership of the 855,589 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
[F6]Represents vesting of 6,002 restricted stock units on the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Documents

2 files

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1

filerCIK 0001727334

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 9:24 PM ET
Size: 18.1 KB

View on SEC.gov